NASDAQ Pharma Gains - Peregrine Pharmaceuticals,

New Post Public Reply Private Reply Replies (0) Message Board
fitzkarz

NASDAQ Pharma Gains - Peregrine Pharmaceuticals, Inc., DARA BioSciences, Inc., and Pacira Pharmaceuticals, Inc. Added to Growing Stock Report's NASDAQ Pharma Watch List.

New York, NY -- ( SBWIRE ) -- 02/02/2013 -- NASDAQ Pharma Gainers: Growing Stock Report adds Peregrine Pharmaceuticals, Inc., DARA BioSciences, Inc., and Pacira Pharmaceuticals, Inc. to their NASDAQ Gainer Watch List.

Peregrine Pharmaceuticals, Inc. (NASDAQ PHM) a biopharmaceutical company that engages in the research and development of monoclonal antibodies for the treatment and diagnosis of cancer and viral infections is active today as shares of the company surged earlier this month after reporting an update on an internal review of its Phase II second-line non-small cell lung cancer trial, the stock closed up (+13.30%) today with 4,199,897 shares traded. Peregrine Pharmaceuticals, Inc. (NASDAQ PHM) is currently up (+443.59%) from its 52 week low, which has prompted Growing Stock Report to add them to their NASDAQ Pharma Percentage Gainer Watch List.

Click Here to See What Other Investors are Saying About Peregrine Pharmaceuticals, Inc.

DARA BioSciences, Inc (NASDAQ ARA) a development stage biopharmaceutical company that engages in the development and commercialization of oncology treatment and supportive care pharmaceutical products in the United Sates closed up (+8.57%) with 2,467,129 shares traded. DARA BioSciences, Inc (NASDAQ ARA) is up (+85.48%) from its 52-week low, which has prompted Growing Stock Report to add them to their NASDAQ Pharma Percentage Gainer Watch List.

Click Here to See What Other Investors are Saying About DARA BioSciences, Inc.

Pacira Pharmaceuticals, Inc. (NASDAQ CRX) a specialty pharmaceutical company that develops, commercializes, and manufactures pharmaceutical products for use in hospitals and ambulatory surgery centers closed up (+7.22%) and is currently up (+120.52%) from its 52-week low. From a technical perspective, PCRX is soaring higher here right above some near-term support at $18.50 with above-average volume. This move has started to push shares of PCRX into new 52-week-high territory and new all-time high territory, which is bullish technical price action. Whenever a stock hits new all-time highs, then it means there’s no more overhead resistance to contend with

Click Here to See What Other Investors are Saying About Pacira Pharmaceuticals, Inc.

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com


SBWire ( http://s.tt/1zhZt )
I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Noble's Q3 2026: A Mixed Bag of Contracts & Losses

Updated Category News Views 86

Noble's Third Quarter: Riding Choppy Waters Sometimes you're up, sometimes you're drowning in red ink. Noble Corporation seemed to catch a bit of both waves this quarter. Contracts: A Silver Lining? The markets felt a jolt with Noble pulling in roughly $560 million in new contracts since July. Not too shabby for a company trying to navigate the muddy waters of today's...

Continue Reading
Post University Expands with New Tech and Health Degrees

Updated Category News Views 56

If you're looking to invest in an education with promising payoffs, you might look into what's cooking over at Post University. They've just dropped a bombshell of new programs sure to get some attention from tech heads and health nuts alike, and I can't help but think there's potential brewing here. New Academic Paths Emerge Post University isn't resting on its...

Continue Reading
GrOwnValve's Personalized Valves Pass Safety Milestone

Updated Category News Views 102

Pioneering Success in Personalized Valve Study GrOwnValve GmbH just hit a big milestone that's caught my attention. Their first-in-human heart valve study wrapped up its six-month run with no prosthesis-related mishaps. Yeah, zero misfires. For five whole patients who've been through the wringer, things held steady. This Berlin startup’s got guts, testing tech that...

Continue Reading
New Era for Small Cell Lung Cancer: Breakthroughs & Challenges

Updated Category News Views 0

Unpacking Small Cell Lung Cancer Progress These days, it feels like we're standing on the brink of something real big in the fight against small cell lung cancer. And I'm not talking about pie-in-the-sky ideas—there are some serious game changers coming down the pike, folks. You see, in the past, this aggressive cancer type was pretty much a death sentence. But thanks...

Continue Reading
Webull Faces Investor Lawsuit: Compliance in Question

Updated Category News Views 77

Webull's Run into Regulatory Fog Well, here we go—another tech company caught with its pants down over alleged ties with China. Webull Corporation (NASDAQ:BULL) is in the crosshairs of a class action lawsuit. Investors are sharpening their pitchforks, and you've got until December 7, 2026, to throw your hat in the ring as lead plaintiff. The Core of the Allegations...

Continue Reading
Endava Class Action: Investor Concerns Unveiled

Updated Category News Views 88

What's Happened with Endava? Endava plc, trading under NYSE:DAVA, just got pummeled. A lawsuit is making waves, targeting investors who bought into Endava between September 2025 and 2026. What's the fuss about? Their stock tanked 25% on September 22, 2026, following an unsettling revelation: the company disclosed serious management and potential accounting problems. A...

Continue Reading
UFP Industries Fortifies Gulf Coast with $27M Buy

Updated Category News Views 91

UFP Industries Makes a Strategic Move Folks, it looks like UFP Industries (NASDAQ: UFPI) is making some solid moves down in the Gulf Coast, and they're shelling out $27 million to do it. This time, they've got their eyes on Apache Products, dba Acme Skid, a company that's been doing the heavy lifting in the pallet manufacturing space in Silsbee, Texas. Apparently, these...

Continue Reading
Exploring Stillness and Spirituality in Artful Expressions

Updated Category News Views 59

A Different Approach to Mindfulness No two readers will walk away from Ihrie Means' We Come Here For The Flowers with the same experience—that's the beauty of this visual feast. The author's way of blending art with deep, spiritual musings is like a refreshing cup of morning joe, hits you when you least expect it. The book doesn’t throw text-heavy sermons at you;...

Continue Reading
Centerspace Sale Faces Scrutiny Amid Investor Concerns

Updated Category News Views 40

Potential Undervaluation Looms Large over Centerspace Sale On a crisp October day, the saga of Centerspace's proposed sale to Independence Realty Trust (NYSE: IRT) is stirring the pot. Charles C. Foti, Jr., Esq., and the law firm Kahn Swick & Foti, LLC are throwing a wrench into the works, questioning the soundness of the whole shebang. The deal, valued at 3.800 shares of...

Continue Reading
Avoid Costly Insurance Pitfalls: First-Time Homeowner Tips

Updated Category News Views 61

The Missteps of Inexperience You'd think buying a house would make folks pay attention to every stitch and nail, but oddly enough, many first-time homeowners trip over the one thing that's supposed to protect their investment—insurance. It's easy to get off on the wrong foot if you're only eyeing that bottom-line premium figure, missing the forest for the trees. Why...

Continue Reading

Top 5 Most Recently Viewed Articles

Viking M&A Opens New Office in Philadelphia to Support Growth

Updated Category News Views 165

Viking M&A Opens New Office in Philadelphia to Support Growth Viking Mergers & Acquisitions is proud to announce its expansion into Philadelphia, marking a significant milestone as the firm opens its ninth office across the United States. This strategic move is aimed at providing lower middle-market advisory services to the vibrant business community in this key...

Continue Reading
Seasonal Basement Waterproofing Tips from Charlie Hill Expert

Updated Category News Views 91

Seasonal Basement Waterproofing Tips from Charlie Hill Homeowners looking to safeguard their basements from moisture have a valuable resource in Charlie Hill, an expert from Great Lakes Waterproofing. His insights, shared in an article by HelloNation, provide a thorough checklist and practical advice for preventing water damage, especially during the spring thaw....

Continue Reading
Sunshine Biopharma Launches Generic Drug, Stock Prices Soar

Updated Category News Views 155

Sunshine Biopharma's Promising News Shares of Sunshine Biopharma Inc. (NASDAQ:SBFM) have seen a notable rise recently, following the announcement from the pharmaceutical company regarding the launch of a new generic prescription drug. This significant development has sparked interest among investors, as the company aims to capture a portion of the cholesterol-lowering...

Continue Reading
Understanding the Impacts of Options Activity on MongoDB Stocks

Updated Category News Views 139

MongoDB Sees Unusual Options Activity Recent transactions in the options market for MongoDB (NASDAQ: MDB) have drawn attention from financial analysts and investors. A detailed examination reveals 63 unusual trades, indicating a heightened level of interest in the stock, showing a mix of bullish and bearish sentiments. Market Sentiment Analysis Analyzing the data, we find...

Continue Reading
AT&T Transfers Ownership of DIRECTV to TPG Capital

Updated Category News Views 348

AT&T Completes Sale of DIRECTV Stake AT&T has successfully concluded the sale of its entire 70% stake in DIRECTV to TPG Capital. This strategic move showcases AT&T's commitment to optimizing its portfolio and enhancing its focus on core areas of growth in the telecommunications sector. The Transaction with TPG Capital This pivotal transaction marks a significant milestone...

Continue Reading